Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-24 @ 3:59 PM
NCT ID:
NCT00196066
Eligibility Criteria:
Inclusion Criteria:
* Patient has documented stenotic or occluded atherosclerotic lesions of the external iliac or common iliac artery.
* Patient has a de novo or restenotic lesion(s) with no prior stent in the target lesion.
* Patient has given informed consent.
Exclusion Criteria:
* Patient is less than 50 years of age
* Patient is participating in another investigational drug or device study.
* Patient has multiple lesions (ipsilateral or in the aorta) that would require a staged procedure.
* Patient has a history of bleeding diathesis or coagulopathy or will refuse blood transfusions.
* Patient has a known hypersensitivity or contraindication to aspirin, clopidogrel, nitinol, or contrast dye that cannot be adequately premedicated.
* Patient is pregnant or breast-feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT00196066
Study Brief:
Protocol Section:
NCT00196066